Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis.
Edurne ArriolaMaría González-CaoManuel DomineJavier De CastroManuel CoboReyes BernabéAlejandro NavarroIvana SullivanJosé Manuel TrigoJoaquín MosqueraLeonardo CramaDolores IslaPublished in: Oncology and therapy (2022)
Combining anti-programmed cell death ligand 1 antibodies with platinum/etoposide is a superior therapeutic approach compared to CT alone for the first-line treatment of patients with ES-SCLC.